Inventor(s)

Abstract

Considerations relating to crystalline form of 1-{(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxybutyl}-4-[(1RS)-1-({methyl[3-({[(methylamino) acetyl] oxy} methyl) pyridin-2-yl]carbamoyl}oxy) ethyl]-1H-1,2,4-triazol-4-ium monosulfate (Isavuconazonium Sulfate) are set out herein.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS